Acro Biomedical Co., Ltd. financial data

Symbol
ACBM on OTC
Location
12175 Visionary Way, Suite 1160, Fishers, IN
State of incorporation
NV
Fiscal year end
December 31
Former names
KILLER WAVES HAWAII, INC (to 1/30/2017)
Latest financial report
10-Q - Q2 2023 - Aug 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 307 % -65%
Debt-to-equity 24.2 % +9.49%
Return On Equity -3.5K % -44.1%
Return On Assets -2.4K % -13.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60M shares 0%
Common Stock, Shares, Outstanding 60M shares 0%
Entity Public Float 128M USD +82.4%
Common Stock, Value, Issued 60K USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Cost of Revenue 296K USD -55.8%
Research and Development Expense 9.44M USD -25.5%
Operating Income (Loss) -15.1M USD -2.54%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.2M USD +20%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -15.1M USD -2.55%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 499K USD +67%
Inventory, Net 296K USD -33.9%
Assets, Current 526K USD -16.1%
Operating Lease, Right-of-Use Asset 13K USD -66%
Assets 539K USD -19.5%
Liabilities, Current 199K USD +145%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 201K USD +71.4%
Retained Earnings (Accumulated Deficit) -31M USD -95.5%
Stockholders' Equity Attributable to Parent 340K USD -40.9%
Liabilities and Equity 539K USD -19.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.57K USD -102%
Net Cash Provided by (Used in) Financing Activities 288 USD -98%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 60M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.68K USD -77.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 5.01M USD +198%
Operating Lease, Liability 25.7K USD -49%
Lessee, Operating Lease, Liability, to be Paid 13.1K USD
Operating Lease, Liability, Current 13K USD -48.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.1K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.01M USD +198%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Additional Paid in Capital 32.3M USD +0.01%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 26.3K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments Due 39.4K USD +222%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%